Aileron Therapeutics, Inc. operates as a clinical stage chemoprotection oncology company in the United States. The company is developing ALRN-6924, which is in Phase 1 trial for solid tumor and lymphoma; Phase 2a clinical trial to treat peripheral T-cell lymphoma; Phase I clinical trial for the treatment of acute myeloid leukemia (AML) and advanced myelodysplastic syndrome (MDS); Phase 1b trial to test the combination of ALRN-6924 and cytarabine, or Ara-C, in patients with MDS; and a Phase 2a combination trial of ALRN-6924 and palbociclib in patients with tumors harboring MDM2 amplifications co-amplifications, as well as for patients with p53-mutated small cell lung cancer that has completed Phase 1b clinical trial. It has a license agreement with Dana-Farber Cancer Institute and Harvard College; and Umicore Precious Metals Chemistry USA, LLC. The company was formerly known as Renegade Therapeutics, Inc. and changed its name to Aileron Therapeutics, Inc. in February 2007. Aileron Therapeutics, Inc. was incorporated in 2001 and is based in Boston, Massachusetts. The 2025 version of the report offers detailed insights into the company's strategies, developments, outlook and drivers. In addition to SWOT Analysis and Financial Overview, the report analyzes key projects, business description, products, services, brands, operating locations, subsidiaries and affiliates of Aileron Therapeutics Inc..
Aileron Therapeutics Inc. business operations across the value chain are included. Further, all major operating and planned locations, related contacts, details of subsidiaries and partnerships of Aileron Therapeutics Inc. are also analyzed.
Detailed SWOT Analysis of the company including key strengths and weaknesses of Aileron Therapeutics Inc. , on which it can build its business along with potential opportunities and threats in the near to medium term future are detailed.
Key employees of the company including the management team and board of directors are listed with their designations. Further, statistics on key parameters such as employee count, organization structure etc is provided.
Financial analysis of Aileron Therapeutics Inc. including key ratios, income statement, cash flow statement and balance sheet are provided for the company. In addition, Key historical events, summary analysis of Aileron Therapeutics Inc. and all latest updates of the company are provided.
The 2025 version of Aileron Therapeutics Inc. report is presented after intensive primary and secondary research processes and it presents the insights in a complete impartial and reader friendly format.
TABLE OF CONTENTS
1.1 List of Tables
1.2 List of Figures
2 Introduction to the Company
2.1 Aileron Therapeutics Inc.- Key Facts
2.2 Aileron Therapeutics Inc.- Geographic Locations
2.3 Aileron Therapeutics Inc.- Subsidiaries and Affiliates
2.4 Aileron Therapeutics Inc.- Business Divisions
2.5 Aileron Therapeutics Inc.- Key Employees
2.5.1 Management Team
2.5.2 Board of Directors
3. Aileron Therapeutics Inc. Strategic Analysis Review
3.1 Aileron Therapeutics Inc.- Key Strategies
3.2 Aileron Therapeutics Inc.- Company Outlook Statement
3.3 Aileron Therapeutics Inc.- SWOT Analysis
3.3.1 Aileron Therapeutics Inc.- Key Strengths
3.3.2 Aileron Therapeutics Inc.- Key Weaknesses
3.3.3 Aileron Therapeutics Inc.- Potential Opportunities
3.3.4 Aileron Therapeutics Inc.- Potential Threats
3.4 Aileron Therapeutics Inc.- Key Competitors
4. Business Description of the Company
4.1 Aileron Therapeutics Inc.- Business Overview
4.2 Aileron Therapeutics Inc.- Operations by Segment
5 Products and Services Details
5.1 Aileron Therapeutics Inc.- Key Products
5.2 Aileron Therapeutics Inc.- Key Service Areas
5.3 Aileron Therapeutics Inc.- Key Brands
6 Company Developments
6.1 Aileron Therapeutics Inc.- Company History
6.2 Aileron Therapeutics Inc.- Latest Developments
7 Financial Analysis
7.1 Aileron Therapeutics Inc.- Income Statements
7.2 Aileron Therapeutics Inc.- Balance Sheet
7.3 Aileron Therapeutics Inc.- Cash Flow Statements
8 Competitors and Industry Analysis
8.1 Aileron Therapeutics Inc.- Direct Competitors
8.2 Aileron Therapeutics Inc.- Competitor Financial Ratios comparison
8.3 Aileron Therapeutics Inc.- Competitor Stock Charts Comparison
8.4 Aileron Therapeutics Inc.- Industry Analysis
9 Appendix
9.1 About SWOTreports
9.2 Sources and Methodology
9.3 Contact Information
P.S.Financial Analysis will be provided only for companies reporting financial data.
Get Free Sample
At SWOT Reports, we understand the importance of informed decision-making in today's dynamic business landscape. To help you experience the depth and quality of our market research reports, we offer complimentary samples tailored to your specific needs.
Start Now! Please fill the form below for your free sample.
Why Request a Free Sample?
Evaluate Our Expertise: Our reports are crafted by industry experts and seasoned analysts. Requesting a sample allows you to assess the depth of research and the caliber of insights we provide.
Tailored to Your Needs: Let us know your industry, market segment, or specific topic of interest. Our free samples are customized to ensure relevance to your business objectives.
Witness Actionable Insights: See firsthand how our reports go beyond data, offering actionable insights and strategic recommendations that can drive your business forward.
Embark on your journey towards strategic decision-making by requesting a free sample from SWOT Reports. Experience the caliber of insights that can transform the way you approach your business challenges.
FAQ's
Gain valuable insights into the company for academic or business research purposes with this comprehensive profile. Key elements, such as SWOT analysis and corporate strategy, are included to support your research needs effectively.
Customer and Supplier Identification: Analyze the company’s business structure, operations, major products, services, and strategies to identify potential customers and suppliers.
Leverage a detailed SWOT analysis to understand and evaluate your competitors' business structures, strategies, and core performance metrics. This analysis offers an up-to-date and objective perspective on the company’s strengths, weaknesses, opportunities, and threats.
Didn’t find what you’re looking for? TALK TO OUR ANALYST TEAM
Need something within your budget? NO WORRIES! WE GOT YOU COVERED!
Reach Out to Us
Industries
Resources
Company
Sign up for Offers & Promotions
- Connect with us
- +91 630 95 25755
- sales@swotreports.com
-
Chat on WhatsApp
